Alfred E. Mann Foundation for Scientific Research 4
4 · Axonics Modulation Technologies, Inc. · Filed Nov 2, 2018
Insider Transaction Report
Form 4
Transactions
- Conversion
Series B-1 Preferred Stock
2018-11-02−771,161→ 0 total→ Common Stock (925,394 underlying) - Conversion
Common Stock
2018-11-02+289,576→ 1,177,576 total - Conversion
Series A Preferred Stock
2018-11-02−125,000→ 0 total→ Common Stock (289,576 underlying) - Conversion
Common Stock
2018-11-02+925,394→ 2,102,970 total
Footnotes (3)
- [F1]Reflects a 1.2-for-1 forward stock split of the Issuer's common stock effected on October 18, 2018.
- [F2]Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series A preferred stock automatically converted into 2.31660 shares of the Issuer's common stock. The A preferred stock had no expiration date.
- [F3]Effective upon the closing of the Issuer's initial public offering of its common stock under the Securities Act of 1933, as amended, each share of Series B-1 preferred stock automatically converted into 1.2 shares of the Issuer's common stock. The B-1 preferred stock had no expiration date.